RNA DIAGNOSTICS ANNOUNCES $5M SERIES A FINANCING ROUND LED BY iGAN PARTNERS

TORONTO – NOV 8, 2018 — Rna Diagnostics Inc., a Canadian company with a patented platform technology providing real-time cancer therapy guidance, announced today the closing of a $5 million Series A financing. The funding was led by iGAN Partners and includes new and  existing investors. MORE>>